Patent · US Active

Antibodies recognizing tau

US10889638B2 · kind B2 · utility

10Cited by
5References
196Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2017
Grant dateJan 12, 2021
Priority date—
Expiry dateMay 2, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.